Jalpa A. Doshi, PhD
Professor of Medicine (General Internal Medicine)
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Fellow, Institute on Aging, University of Pennsylvania
Director, Value Based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania
Director, Economic Evaluations Unit, Center for Evidence-Based Practice, University of Pennsylvania Health System
Associate Director , ECRI-Penn Medicine Evidence-based Practice Center (EPC) funded by the Agency for Healthcare Research and Quality
Senior Fellow, Center for Public Health Initiatives, University of Pennsylvania
Department: Medicine
Contact information
1223 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
423 Guardian Drive
Philadelphia, PA 19104
Office: (215) 898-7989
Fax: (215) 898-0611
Fax: (215) 898-0611
Education:
BPharm (Pharmaceutical Sciences)
Bombay College of Pharmacy, University of Bombay (Mumbai), India, 1999.
MS (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2001.
PhD (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2003.
Permanent linkBPharm (Pharmaceutical Sciences)
Bombay College of Pharmacy, University of Bombay (Mumbai), India, 1999.
MS (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2001.
PhD (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2003.
Selected Publications
Li P, Prajapati G, Geng Z, Ladage V, Arduino JM, Watson D, Gross R, Doshi JA: "Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program" AIDS and Behavior In Press 2023Li P, Benson C, Geng Z, Seo S, Patel C, Doshi JA: "Antipsychotic Utilization, Healthcare Resource Use and Costs, and Quality of Care among Fee-for-service Medicare Beneficiaries with Schizophrenia in the United States." Journal of Medical Economics 26(1): 525-536, 2023.
Doshi JA, Eilers M, Gupta A, Pauly M, Olssen A: "Is Employment Group Insurance Financing of Expensive Gene Therapies Threatened in the United States?" Health Affairs Scholar 1(4): 1-6, 2023.
Huntington S, Nigris E, Puckett J, Kamal-Bahl S, Farooquib M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA: "Ibrutinib Discontinuation and Associated Factors in a Real-world National Sample of Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia" Leukemia & Lymphoma In Press 2023.
Dean L, Nunn AS, Chang HY, Goedel WC, Chan PA, Doshi JA: "Estimating the Impact of Out-of-Pocket Cost Changes on the Abandonment of HIV Pre-exposure Prophylaxis (PrEP) Prescriptions" Health Affairs In Press 2023.
Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi JA, Huntington SF.: "Assessing Unmet Need among Elderly Medicare Beneficiaries with Mantle Cell Lymphoma: An Analysis of Treatment Patterns, Survival, Healthcare Resource Utilization, and Costs" Leukemia & Lymphoma Page: 1-13, 2023 Notes: Epub ahead of print.
Li P, Benson C, Geng Z, Seo S, Patel C, Doshi JA : "Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries with Schizophrenia" JAMA Network Open 6(9): e2334016, 2023.
Huntington SF, Manzoor BS, Puckett JT, Kamal-Bahl S, Alhasani H, Ravelo A, Jawaid D, Doshi JA: "Real-world Adherence and Discontinuation among Medicare Beneficiaries initiating Venetoclax vs. BTKis in Relapsed/Refractory Chronic Lymphocytic Leukemia." Leukemia & Lymphoma 21:1-8, 2023 Notes: Epub ahead of print.
Doshi JA, Li P, Geng Z, Seo S, Patel C, Benson C : "Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia" Psychiatric Services In Press 2023.
Dubberke ER, Puckett JT, Obi EN, Kamal-Bahl S, Desai K, Stuart B, Doshi JA.: "Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes" Open Forum Infect Dis 9(10): ofac435, 2022.